Cocaine and specific cocaine metabolites induce von willebrand factor release from endothelial cells in a tissue-specific manner

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 33, Issue 6, 2013, Pages 1230-1237

  Hobbs, William E ^a,b   Moore, Emily E ^a   Penkala, Rebecca A ^a   Bolgiano, Douglas D ^a,c   López, José A ^a,b  

^a PUGET SOUND BLOOD CENTER   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

Cocaine; Endothelium; Platelets; Thrombosis; Von Willebrand factor

Indexed keywords

BENZOYLECGONINE; COCAINE; CYCLIC AMP DEPENDENT PROTEIN KINASE; ECGONINE METHYL ESTER; HOMOCOCAINE; NORCOCAINE; VON WILLEBRAND FACTOR;

ARTICLE; CONTROLLED STUDY; CORONARY ARTERY; HUMAN; HUMAN CELL; MICROVASCULATURE; PRIORITY JOURNAL; PROTEIN SECRETION; THROMBOCYTE; UMBILICAL VEIN ENDOTHELIAL CELL;

COCAINE; ENDOTHELIUM; PLATELETS; THROMBOSIS; VON WILLEBRAND FACTOR;

BRAIN; CELLS, CULTURED; COCAINE; CORONARY VESSELS; ENDOTHELIAL CELLS; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; P-SELECTIN; SENSITIVITY AND SPECIFICITY; THROMBOSIS; VON WILLEBRAND FACTOR;

EID: 84879102721     PISSN: 10795642     EISSN: 15244636     Source Type: Journal    
DOI: 10.1161/ATVBAHA.113.301436     Document Type: Article

References (49)

1. Bhattacharya P, Taraman S, Shankar L, Chaturvedi S, Madhavan R. Clinical profiles, complications, and disability in cocaine-related ischemic stroke. J Stroke Cerebrovasc Dis. 2011;20:443-449.
2. Phillips K, Luk A, Soor GS, Abraham JR, Leong S, Butany J. Cocaine cardiotoxicity: a review of the pathophysiology, pathology, and treatment options. Am J Cardiovasc Drugs. 2009;9:177-196.
3. Lisse JR, Davis CP, Thurmond-Anderle ME. Upper extremity deep venous thrombosis: increased prevalence due to cocaine abuse. Am J Med. 1989;87: 457-458.
4. Volcy J, Nzerue CM, Oderinde A, Hewan-Iowe K. Cocaine-induced acute renal failure, hemolysis, and thrombocytopenia mimicking thrombotic thrombocytopenic purpura. Am J Kidney Dis. 2000;35:-e3.
5. Qureshi AI, Suri MF, Guterman LR, Hopkins LN. Cocaine use and the likelihood of nonfatal myocardial infarction and stroke: data from the Third National Health and Nutrition Examination Survey. Circulation. 2001;103:502-506.
6. Mittleman MA, Mintzer D, Maclure M, Tofler GH, Sherwood JB, Muller JE. Triggering of myocardial infarction by cocaine. Circulation. 1999;99:2737-2741.
7. Johanson CE, Fischman MW. The pharmacology of cocaine related to its abuse. Pharmacol Rev. 1989;41:3-52.
8. Rose JS. Cocaethylene: a current understanding of the active metabolite of cocaine and ethanol. Am J Emerg Med. 1994;12:489-490.
9. Andrews P. Cocaethylene toxicity. J Addict Dis. 1997;16:75-84.
10. Benzaquen BS, Cohen V, Eisenberg MJ. Effects of cocaine on the coronary arteries. Am Heart J. 2001;142:402-410.
11. Treadwell SD, Robinson TG. Cocaine use and stroke. Postgrad Med J. 2007;83:389-394.
12. Konzen JP, Levine SR, Garcia JH. Vasospasm and thrombus formation as possible mechanisms of stroke related to alkaloidal cocaine. Stroke. 1995;26:1114-1118.
13. Lucena J, Blanco M, Jurado C, Rico A, Salguero M, Vazquez R, Thiene G, Basso C. Cocaine-related sudden death: a prospective investigation in south-west Spain. Eur Heart J. 2010;31:318-329.
14. Karlsson G, Rehman J, Kalaria V, Breall JA. Increased incidence of stent thrombosis in patients with cocaine use. Catheter Cardiovasc Interv. 2007;69: 955-958.
15. Padilla A, Moake JL, Bernardo A, Ball C, Wang Y, Arya M, Nolasco L, Turner N, Berndt MC, Anvari B, López JA, Dong JF. P-selectin anchors newly released ultralarge von Willebrand factor multimers to the endothelial cell surface. Blood. 2004;103:2150-2156.
16. Huang J, Roth R, Heuser JE, Sadler JE. Integrin alpha(v)beta(3) on human endothelial cells binds von Willebrand factor strings under fluid shear stress. Blood. 2009;113:1589-1597.
17. Dong JF, Moake JL, Nolasco L, Bernardo A, Arceneaux W, Shrimpton CN, Schade AJ, McIntire LV, Fujikawa K, López JA. ADAMTS-13 rapidly cleaves newly secreted ultralarge von Willebrand factor multimers on the endothelial surface under flowing conditions. Blood. 2002;100:4033-4039.
18. Chen J, López JA. Interactions of platelets with subendothelium and endothelium. Microcirculation. 2005;12:235-246.
19. Siegel AJ, Sholar MB, Mendelson JH, Lukas SE, Kaufman MJ, Renshaw PF, McDonald JC, Lewandrowski KB, Apple FS, Stec JJ, Lipinska I, Tofler GH, Ridker PM. Cocaine-induced erythrocytosis and increase in von Willebrand factor: evidence for drug-related blood doping and prothrombotic effects. Arch Intern Med. 1999;159:1925-1929.
20. Dressler FA, Malekzadeh S, Roberts WC. Quantitative analysis of amounts of coronary arterial narrowing in cocaine addicts. Am J Cardiol. 1990;65:303-308.
21. Ramondo AB, Mistrorigo F, Angelini A. Intimal hyperplasia and cystic medial necrosis as substrate of acute coronary syndrome in a cocaine abuser: an in vivo/ex vivo pathological correlation. Heart. 2009;95:82.
22. Kolodgie FD, Virmani R, Cornhill JF, Herderick EE, Smialek J. Increase in atherosclerosis and adventitial mast cells in cocaine abusers: an alternative mechanism of cocaine-Associated coronary vasospasm and thrombosis. J Am Coll Cardiol. 1991;17:1553-1560.
23. Gan X, Zhang L, Berger O, Stins MF, Way D, Taub DD, Chang SL, Kim KS, House SD, Weinand M, Witte M, Graves MC, Fiala M. Cocaine enhances brain endothelial adhesion molecules and leukocyte migration. Clin Immunol. 1999;91:68-76.
24. Sáez CG, Olivares P, Pallavicini J, Panes O, Moreno N, Massardo T, Mezzano D, Pereira J. Increased number of circulating endothelial cells and plasma markers of endothelial damage in chronic cocaine users. Thromb Res. 2011;128:-e18-e23.
25. Kolodgie FD, Wilson PS, Mergner WJ, Virmani R. Cocaine-induced increase in the permeability function of human vascular endothelial cell monolayers. Exp Mol Pathol. 1999;66:109-122.
26. Blann AD. Plasma von Willebrand factor, thrombosis, and the endothelium: the first 30 years. Thromb Haemost. 2006;95:49-55.
27. Substance Abuse and Mental Health Services Administration, Center for Behavioral Health Statistics and Quality (formerly the Office of Applied Studies). The DAWN Report: Highlights of the 2009 Drug Abuse Warning Network (DAWN) Findings on Drug-Related Emergency Department Visits. Rockville, MD: December 28, 2010. http://www.oas.samhsa. gov/2k10/DAWN034/EDHighlights.htm. Accessed April 19, 2013.
28. Schwartz BG, Rezkalla S, Kloner RA. Cardiovascular effects of cocaine. Circulation. 2010;122:2558-2569.
29. Esse K, Fossati-Bellani M, Traylor A, Martin-Schild S. Epidemic of illicit drug use, mechanisms of action/addiction and stroke as a health hazard. Brain Behav. 2011;1:44-54.
30. Killam AL. Cardiovascular and thrombosis pathology associated with cocaine use. Hematol Oncol Clin North Am. 1993;7:1143-1151.
31. Heesch CM, Wilhelm CR, Ristich J, Adnane J, Bontempo FA, Wagner WR. Cocaine activates platelets and increases the formation of circulating platelet containing microaggregates in humans. Heart. 2000;83:688-695.
32. Kugelmass AD, Oda A, Monahan K, Cabral C, Ware JA. Activation of human platelets by cocaine. Circulation. 1993;88:876-883.
33. Kugelmass AD, Shannon RP, Yeo EL, Ware JA. Intravenous cocaine induces platelet activation in the conscious dog. Circulation. 1995;91: 1336-1340.
34. Rinder HM, Ault KA, Jatlow PI, Kosten TR, Smith BR. Platelet alphagranule release in cocaine users. Circulation. 1994;90:1162-1167.
35. Pradhan L, Mondal D, Chandra S, Ali M, Agrawal KC. Molecular analysis of cocaine-induced endothelial dysfunction: role of endothelin-1 and nitric oxide. Cardiovasc Toxicol. 2008;8:161-171.
36. McKee SA, Applegate RJ, Hoyle JR, Sacrinty MT, Kutcher MA, Sane DC. Cocaine use is associated with an increased risk of stent thrombosis after percutaneous coronary intervention. Am Heart J. 2007;154:159-164.
37. Arya M, Anvari B, Romo GM, Cruz MA, Dong JF, McIntire LV, Moake JL, López JA. Ultralarge multimers of von Willebrand factor form spontaneous high-strength bonds with the platelet glycoprotein Ib-IX complex: studies using optical tweezers. Blood. 2002;99:3971-3977.
38. Chen J, Fu X, Wang Y, Ling M, McMullen B, Kulman J, Chung DW, López JA. Oxidative modification of von Willebrand Factor by neutrophil oxidants inhibits its cleavage by ADAMTS13. Blood. 2010;115: 706-712.
39. Peterson DM, Stathopoulos NA, Giorgio TD, Hellums JD, Moake JL. Shear-induced platelet aggregation requires von Willebrand factor and platelet membrane glycoproteins Ib and IIb-IIIa. Blood. 1987;69: 625-628.
40. Moake JL, Rudy CK, Troll JH, Weinstein MJ, Colannino NM, Azocar J, Seder RH, Hong SL, Deykin D. Unusually large plasma factor VIII:von Willebrand factor multimers in chronic relapsing thrombotic thrombocytopenic purpura. N Engl J Med. 1982;307:1432-1435.
41. Yao H, Duan M, Buch S. Cocaine-mediated induction of platelet-derived growth factor: implication for increased vascular permeability. Blood. 2011;117:2538-2547.
42. Lee YW, Hennig B, Fiala M, Kim KS, Toborek M. Cocaine activates redox-regulated transcription factors and induces TNF-Alpha expression in human brain endothelial cells. Brain Res. 2001;920:125-133.
43. Brogan WC 3rd, Lange RA, Glamann DB, Hillis LD. Recurrent coronary vasoconstriction caused by intranasal cocaine: possible role for metabolites. Ann Intern Med. 1992;116:556-561.
44. Kurth CD, Monitto C, Albuquerque ML, Feuer P, Anday E, Shaw L. Cocaine and its metabolites constrict cerebral arterioles in newborn pigs. J Pharmacol Exp Ther. 1993;265:587-591.
45. López JA, Dong JF. Shear stress and the role of high molecular weight von Willebrand factor multimers in thrombus formation. Blood Coagul Fibrinolysis. 2005;16:S11-S16.
46. Benowitz NL. Clinical pharmacology and toxicology of cocaine. Pharmacol Toxicol. 1993;72:3-12.
47. Lange RA, Hillis LD. Cardiovascular complications of cocaine use. N Engl J Med. 2001;345:351-358.
48. Vongpatanasin W, Mansour Y, Chavoshan B, Arbique D, Victor RG. Cocaine stimulates the human cardiovascular system via a central mechanism of action. Circulation. 1999;100:497-502.
49. Patel R, Shah R, Baredes S, Spillert CR, Lazaro EJ. Nasal toxicity of cocaine: a hypercoagulable effect? J Natl Med Assoc. 2000;92:39-41.